697
Views
2
CrossRef citations to date
0
Altmetric
Editorial

The role of genetic screening in medullary thyroid cancer: a clinician’s view on the recent ATA guidelines

References

  • Wells SA, Asa SL, Dralle H, et al. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma. the american thyroid association guidelines task force on medullary thyroid carcinoma. Thyroid 2015
  • Bihan H, Baudin E, Meas T, et al. Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma. Head Neck 2012;34(4):493-8
  • Miyauchi A, Futami H, Hai N, et al. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res 1999;90(1):1-5
  • Nakao KT, Usui T, Ikeda M, et al. Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis. Head Neck 2013;35(12):E363-8
  • Bartsch DK, Hasse C, Schug C, et al. A RET double mutation in the germline of a kindred with FMTC. Exp Clin Endocrinol Diabetes 2000;108(2):128-32
  • Valente FO, Dias da Silva MR, Camacho CP, et al. Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families. J Endocrinol Invest 2013;36(11):975-81
  • Machens A, Spitschak A, Lorenz K, et al. Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation? Clin Endocrinol (Oxf) 2011;75(6):801-5
  • Colombo-Benkmann M, Li Z, Riemann B, et al. Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma. Eur J Endocrinol 2008;158(6):811-16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.